title: [Prediction of the outcome of IFN therapy in type C chronic hepatitis from serological grouping of hepatitis C virus].
abstract: We investigated the relationship between serological grouping of hepatitis C virus and the response to IFN therapy in type C chronic hepatitis. In group I, responders were low (28%) with a high incidence of recurrence of HCV-RNA (72%). By contrast, in group II, responders were high (62%) and recurrence of HCV-RNA (17%) was low. Serological grouping of hepatitis C virus is useful in the prediction of the outcome of IFN therapy in type C chronic hepatitis.
authors.affiliation: First Department of Internal Medicine, Kanazawa University School of Medicine.
authors.forename: A
authors.initials: A
authors.lastname: Sakai
authors.forename: M
authors.initials: M
authors.lastname: Yanagi
authors.forename: M
authors.initials: M
authors.lastname: Unoura
authors.forename: K
authors.initials: K
authors.lastname: Kobayashi
mesh_terms: D002908:Chronic Disease; D005838:Genotype; D016174:Hepacivirus / Q000145:classification* / Q000235:genetics; D006526:Hepatitis C / Q000628:therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D012367:RNA, Viral / Q000097:blood; D012008:Recurrence; D012703:Serotyping; D016896:Treatment Outcome
chemical_list: D012367:RNA, Viral; D007372:Interferons